Literature DB >> 32212811

Association of Diabetes with Oral Cancer- an Enigmatic Correlation.

Mounika Reddy Mekala1, Balaji Babu Bangi1, Jayalatha N2, Rajasekhar Reddy Lebaka3, Lakshmi Kavitha Nadendla1, Uday Ginjupally1.   

Abstract

INTRODUCTION: Association of diabetes mellitus (DM) with head and neck cancers (HNC) is still controversial. In some studies, diabetic patients had an increased risk of cancer at some HNC subsites like oral cancer, while in other studies this risk was decreased. So, the present study aims to evaluate the association of diabetes mellitus, oral cancer with and without metformin and the role of habits in association with DM and metformin in the etiology of oral cancer.
MATERIALS AND METHODS: This study was undertaken in the Kamineni Institute of Dental Sciences in collaboration with MNJ Institute of Oncology and Regional Cancer Centre, Hyderabad. The study includes 2 main groups, they are 500 Oral cancer patients and Control group includes 500 age and gender-matched patients with habits without any oral precancerous lesion/conditions. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression.
RESULTS: Out of 1000 subjects inverse relation of DM with oral cancer was observed. On comparison between oral cancer, diabetes and habits in study group and control group, decreased risk was observed with smokers (OR: 1.131and 95%CI: 0.68 -1.86) and non-chewers (OR: 2.43 and 95% CI: 1.31 - 4.49) and non-alcoholics (OR: 1.78 and 95% C.I:1.18 - 2.68). Metformin use among diabetic participants was associated with a decreased risk of oral cancer (OR: 0.51 and 95% C.I: 0.33 - 0.77). A negative association was observed in smokers (OR: 0.19 and 95% C.I.: 0.078 - 0.459), non-chewers (OR: 0.24 and 95% C.I : 0.11- 0.53) and non-alcoholics (OR: 0.46 and 95% C.I. : 0.29 - 0.727).
CONCLUSION: Thus the present population based study results suggest an inverse association of DM and oral cancer with metformin and negative association of habits with DM and Metformin in etiology of oral cancer.

Entities:  

Keywords:  Diabetes Mellitus (DM); Metformin; Tobacco; chewing tobacco and alcohol; oral cancer

Year:  2020        PMID: 32212811     DOI: 10.31557/APJCP.2020.21.3.809

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  Point-of-care HbA1c Measurements in Oral Cancer and Control Patients in Hungary.

Authors:  Adam Vegh; Daniel Vegh; Dorottya Banyai; Gabor Kammerhofer; Zita Biczo; Balazs Voros; Marta Ujpal; Juan Francisco Peña-Cardelles; Zehra Yonel; Arpad Joob-Fancsaly; Peter Hermann; Zsolt Nemeth
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

2.  Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yu Jiao; Dongjuan Liu; Yi Sun; Zitong Chen; Sai Liu
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

Review 3.  Genetic alterations and clinical dimensions of oral cancer: a review.

Authors:  Keerthana Karunakaran; Rajiniraja Muniyan
Journal:  Mol Biol Rep       Date:  2020-10-21       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.